Coral Springs, Florida (PRWEB) October 06, 2015
Unless you were living with it, it's likely that you were unaware of male sexual dysfunction until the late 90's and beyond when pharmaceutical companies started huge campaigns for treatment of Erectile Dysfunction. Today, Viagra and Cialis ads continue to run on television around the clock.
Erectile Dysfunction is not the only form of male sexual dysfunction. A condition called Peyronie's Disease, that can affect even young men, has gone largely overlooked, and existing treatments have not met with much success. Dr. Michael Zahalsky a Florida urologist, fellowship trained in male sexual dysfunction, and pioneer in the use of biologics in Urology, is on a mission to help men affected by all male sexual dysfunction -- including Peyronie's Disease. As a result of his work, patients are experiencing groundbreaking success, thanks to the help of a trial using amniotic stem cells and growth factors.
Peyronie's Disease is characterized by the presence of fibrous plaque, or scar tissue, that causes an abnormal curvature of the penis during an erection. Often, this can make it difficult to obtain or maintain an erection, and the erections are painful. It has been estimated that up to 7% of the male population is affected by Peyronie’s Disease. Additionally, almost 30 million US men are affected by Erectile Dysfunction, a condition usually caused by abnormal blood flow to the penis. This week in The Journal of the American Osteopathic Association, Dr. Zahalsky published his groundbreaking results using amniotic stem cells and growth factors for Peyronie’s Disease. This is the first human study of its kind. He says his research on Erectile Dysfunction has already been accepted for publication in the same Journal.
"Patients who suffer from male sexual dysfunction suffer from so much more than the inability to perform," says Dr. Zahalsky. "They're generally unhappier, and can suffer from lack of confidence that bleeds beyond the bedroom leading to depression, anxiety, sleeplessness and more. Because Peyronie's can affect men even in their 20's, it's a condition that without treatment, can have a damaging effect on their overall lifetime happiness. I knew we had to find a better way to treat this."
Previous Peyronie's treatment have involved long series of injection, grafts, and implants. Dr. Zahalsky, a leader in medical research and emerging treatment methods, has been treating patients with his patent pending methodology using autologous stem cell injections, amniotic cells, amniotic fluid, and growth factors. The results -- published in the October issue of The Journal of the American Osteopathic Association -- suggest that using mesenchymal stem cells may be beneficial and effective as a nonsurgical treatment in patients with PD, and that future studies are warranted.
The most promising results of the study included the effect of the treatment on fibrous plaque material found in the penis. In the study, 7 of the 10 fibrous plaques disappeared completely, all patients had an improvement in blood flow, and curvature of the penis dramatically improved. “As far as we know, this was the first ever study on the use of injectable stem cells to manage Peyronie’s Disease in humans,” says Dr. Zahalsky. “Our entire team is thrilled with the early results from the study, and we look forward to continuing our research and educating medical practitioners and patients on this evolving field of urologic biologics.”
Dr. Zahalsky will be presenting the results of the study at the IV World Congress of Medical Sexology in Miami on October 10, 2015. International Impotency Awareness Month begins November 1.
Dr. Michael Zahalsky is available at 954-714-8200.